The Valley Desk

NCT05355402 · Interventional trial

A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia

Overall registry status Completed

Phase 2

Conditions Atherosclerotic Cardiovascular Disease, Hypertriglyceridemia, Severe Hypertriglyceridemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov